Seek immediate medical attention (call 999 or attend A&E) if you experience: Severe, sudden abdominal pain radiating to the back, which may indicate pancreatitisa rare but serious side effect of GLP-1 receptor agonists Persistent vomiting preventing fluid intake Signs of severe dehydration (dizziness, reduced urination, confusion) Symptoms of bowel obstruction (severe bloating, inability to pass wind or stools, vomiting) Your GP may wish to review your Mounjaro dose, as dose reduction or temporary treatment interruption can sometimes resolve gastrointestinal side effects whilst maintaining glycaemic benefits
And the safety profile and discontinuation rates are consistent with other established members of the broadening class of GLP-1 medicines, which is reassuring, says Drucker, who has previously consulted for Eli Lilly but was also not involved in the trial
In her HBO documentary, Being Serena, one scene shows her coach talking with her about the need for her to lose weight
SGLT2 inhibitors are preferred in people with HF or at high-risk for HF, whereas GLP-1 receptor agonists are favored for those requiring significant weight loss, ASCVD risk reduction, CKD management, or in whom mitigation of metabolic dysfunction-associated steatotic liver disease (MASLD) or steatohepatitis is a clinical priority [84]
When you use GLP-1 Treatments, Semaglutide or Tirzepatide, if you attempt to overeat, your body will signal you with a clear message: "That's enough." At a glance, GLP-1 Treatments, Semaglutide or Tirzepatide helps you lose weight in a few ways, such as: GLP-1 Treatments, Semaglutide or Tirzepatide slows down stomach emptying after you're done eating
Consider digestive enzymes Digestive enzymes can help break down food, decreasing the buildup of gas, supporting gut health, and reducing excessive belching